Loading...
Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond One Year after Percutaneous Coronary Intervention: An Analysis from the Randomized Dual Antiplatelet Therapy Study
IMPORTANCE: Dual antiplatelet therapy after percutaneous coronary intervention (PCI) reduces ischemia at the expense of increased bleeding. OBJECTIVE: To develop a clinical decision tool to identify patients expected to derive benefit vs. harm from continuing thienopyridine beyond one year after PCI...
Na minha lista:
| Udgivet i: | JAMA |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5408574/ https://ncbi.nlm.nih.gov/pubmed/27022822 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2016.3775 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|